Literature DB >> 15899570

Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application.

Mingshe Zhu1, Weiping Zhao, Natasha Vazquez, James G Mitroka.   

Abstract

TopCount, a microplate scintillation counter (MSC), has been recently employed as an off-line liquid radiochromatographic detector for radioactive metabolite profile analysis. The present study was undertaken to validate TopCount for metabolite profiling with respect to sensitivity, accuracy, precision and radioactivity recovery. Matrix effects of various human samples on TopCount performance and capability of MSC for volatile metabolite analysis were also investigated. TopCount had a limit of detection (LOD) of 5 DPM and a limit of quantification (LOQ) of 15 DPM for [(14)C]-labeled compounds at a 10min counting time. It was two-fold more sensitive than a liquid scintillation counter (LSC), and 50-100-fold more sensitive than a radioactivity flow detector (RFD). TopCount had comparable accuracy and precision to RFD, and comparable precision to LSC for determining relative abundance of metabolites. Human liver microsome incubation (up to 1 mL), plasma (up to 1 mL), urine (up to 2 mL) and feces (up to 50mg) had no significant quenching effects on TopCount performance. Benzoic acid, a volatile metabolite, was detected by TopCount, but not by Microbeta counter after microplates were dried under vacuum. Radioactivity recovery in HPLC-MSC analysis was reliably determined using an LSC-based method. Examples of using HPLC-MSC for analysis of low levels of radioactive metabolites are presented, including determination of plasma metabolite profile, in vitro reactive metabolites trapped by [(3)H]glutathione, and metabolite concentrations in an enzyme kinetic experiment. The data from this study strongly suggest that HPLC in combination with TopCount is a viable alternative analytical tool for detection and quantification of low levels of radioactive metabolites in biological fluids.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899570     DOI: 10.1016/j.jpba.2005.03.012

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Metabolite profiling of the multiple tyrosine kinase inhibitor lenvatinib: a cross-species comparison.

Authors:  Anne-Charlotte Dubbelman; Cynthia M Nijenhuis; Robert S Jansen; Hilde Rosing; Hitoshi Mizuo; Shinki Kawaguchi; David Critchley; Robert Shumaker; Jan H M Schellens; Jos H Beijnen
Journal:  Invest New Drugs       Date:  2016-03-28       Impact factor: 3.850

2.  In vitro glucuronidation of 2,2-bis(bromomethyl)-1,3-propanediol by microsomes and hepatocytes from rats and humans.

Authors:  Golriz Rad; Simone I Hoehle; Robert K Kuester; I Glenn Sipes
Journal:  Drug Metab Dispos       Date:  2010-03-03       Impact factor: 3.922

3.  Pharmacokinetics and excretion of (14)C-lenvatinib in patients with advanced solid tumors or lymphomas.

Authors:  Anne-Charlotte Dubbelman; Hilde Rosing; Cynthia Nijenhuis; Alwin D R Huitema; Marja Mergui-Roelvink; Anubha Gupta; David Verbel; Gary Thompson; Robert Shumaker; Jan H M Schellens; Jos H Beijnen
Journal:  Invest New Drugs       Date:  2014-11-08       Impact factor: 3.850

4.  Effects of dose and route on the disposition and kinetics of 1-butyl-1-methylpyrrolidinium chloride in male F-344 rats.

Authors:  G A Knudsen; Y Cheng; R K Kuester; M J Hooth; I G Sipes
Journal:  Drug Metab Dispos       Date:  2009-08-24       Impact factor: 3.922

Review 5.  The role of ubiquitin ligases in cardiac disease.

Authors:  Monte S Willis; Ariana Bevilacqua; Thomas Pulinilkunnil; Petra Kienesberger; Manasi Tannu; Cam Patterson
Journal:  J Mol Cell Cardiol       Date:  2013-11-19       Impact factor: 5.000

6.  Absorption, distribution, metabolism, and excretion of 2,2-bis(bromomethyl)-1,3-propanediol in male fischer-344 rats.

Authors:  Simone I Hoehle; Gabriel A Knudsen; J Michael Sanders; I Glenn Sipes
Journal:  Drug Metab Dispos       Date:  2008-11-24       Impact factor: 3.922

7.  A unique automation platform for measuring low level radioactivity in metabolite identification studies.

Authors:  Joel Krauser; Markus Walles; Thierry Wolf; Daniel Graf; Piet Swart
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

8.  Separation and degradation detection of nanogram-per-litre concentrations of radiolabelled steroid hormones using combined liquid chromatography and flow scintillation analysis.

Authors:  Roman Lyubimenko; Bryce S Richards; Andrey Turshatov; Andrea I Schäfer
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.